Ligelizumab Gets Breakthrough Tx Status for Chronic Spontaneous Urticaria
Ligelizumab is a high-affinity monoclonal anti-immunoglobulin E (IgE) antibody.
Miscellaneous Dermatological Conditions
Clinical Challenge: Asymptomatic Growth on Cheek
A woman requests the removal of an asymptomatic growth on her cheek that has been present for 1 year.
Clinical Challenge: Growth Under Eyes
A 51-year-old woman requested removal of growths under both eyes. Can you make the correct diagnosis?
New Drug Product: Zilxi
This slideshow shows drug information for Zilxi. Click here for the complete Zilxi monograph.
Clinical Challenge: Nonpruritic Rash Affecting Both Legs
A 38-year-old woman presents with a rash affecting her legs. Can you make the correct diagnosis?
Clinical Challenge: Red, Itchy Rash of the Upper Body
A 50-year-old man is referred for evaluation of a rash first noted approximately 2 months ago. He states that the rash is itchy and is accentuated by rubbing and applying pressure. Despite a 2-week course of cetirizine, the condition has not improved. The patient is currently prescribed a thiazide diuretic to control his hypertension. Examination…
Clinical Challenge: Red, Bumpy Rash on a Child
A 6-year-old boy presents with a red, bumpy rash located on his face, elbows, and knees that has been present for 1 week. The parents report that the child has a cough but no fever, chills, oral aphthae, sore throat, diarrhea, or arthralgias. The child has not been near others with similar symptoms and has…
Clinical Challenge: Nodular Growth on Trunk
A 40-year-old man presents with a nodular growth on his trunk that has been present for 10 years. Can you make the correct diagnosis?
Clinical Challenge: Pigmented Lesions on the Heel
An 86-year-old man presents with a 1-year history of asymptomatic, pigmented lesions on the heel of his right foot. Can you make the correct diagnosis?
Novel Medication Relieves Pruritus in Hemodialysis Cases
Difelikefalin, an investigational intravenous drug, improved moderate to severe itching compared with placebo in patients on hemodialysis, according to phase 3 trial results.
